Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Epidemiology and Risk Factors
-
1. The changing prevalence of asthma
- Dr. Deborah Jarvis
-
2. Recent advances in asthma genetics
- Prof. Miriam Moffatt
-
3. Asthma: an epidemic caused by epigenetics?
- Prof. David Schwartz
-
4. Role of the microbiota in asthma
- Prof. B. Brett Finlay
-
5. Diet and asthma
- Prof. Lewis Smith
-
6. Obesity and asthma
- Prof. Anne Dixon
-
7. Occupational asthma: management beyond the textbooks
- Prof. Paul Cullinan
- Clinical Phenotypes
-
8. The origins of asthma
- Prof. Peter Sly
-
9. Pre-school wheeze
- Prof. Andrew Bush
-
11. Smoking asthmatics
- Prof. Neil Thomson
-
12. Aspirin exacerbated respiratory disease
- Prof. Chris Corrigan
- Mechanisms of Asthma
-
13. Advances in asthma: airway inflammation
- Prof. William Busse
-
14. The role of mast cells in asthma
- Prof. Peter Bradding
-
15. Dendritic cells in asthma
- Prof. Bart Lambrecht
-
16. The airway smooth muscle in asthma
- Prof. Judith Black
-
17. Role of virus infection in asthma 1
- Prof. Sebastian Johnston
-
18. Role of virus infection in asthma 2
- Prof. Sebastian Johnston
-
19. Severe asthma: characterisation, mechanisms & treatment
- Prof. Fan Chung
-
20. Steroid resistance in asthma: mechanisms and potential therapies
- Prof. Ian Adcock
-
21. Macrophage in asthma
- Prof. Douglas Robinson
- Diagnosis of Asthma
-
22. Physiology of asthma and involvement of small airways
- Prof. Charles G. Irvin
-
23. Induced sputum in asthma
- Prof. Antonio Spanevello
- Therapy and Management
-
25. Pulmonary drug delivery
- Prof. Anthony J. Hickey
-
26. The management of chronic asthma
- Prof. Mark Fitzgerald
-
27. Inhaled corticosteroids and beta2-agonists
- Dr. Omar S. Usmani
-
28. Management of "difficult asthma"
- Prof. Elisabeth Bel
-
29. Management of acute exacerbations of asthma
- Dr. Chris Fanta
-
30. Non-pharmacological treatments for asthma
- Prof. Neil Thomson
-
31. Asthma: beyond the prescription
- Prof. Martyn Partridge
-
32. New drugs for asthma
- Prof. Peter Barnes
-
33. Anti-IgE therapy for asthma
- Dr. Andrew Menzies-Gow
- Archived Lectures *These may not cover the latest advances in the field
-
34. New drugs for asthma
- Prof. Peter Barnes
-
35. Asthma phenotypes in children
- Prof. Andrew Bush
-
36. Steroid resistance in asthma: mechanisms and potential therapies
- Prof. Ian Adcock
-
37. Severe asthma in children
- Prof. Andrew Bush
Printable Handouts
Navigable Slide Index
- Introduction
- Hygiene hypothesis
- “Disappearing microbe” hypothesis
- Microbiota affect immune system development
- Why study asthma?
- Epidemiological evidence
- Do antibiotic affect asthma susceptibility?
- Lung inflammation
- Neonatal antibiotic treatment and asthma severity
- Vancomycin treatment profoundly alters gut flora
- Bacterial taxa correlate with exacerbated asthma
- Tregs may play role in asthma
- Is there a window that microbiota impacts?
- Perinatal antibiotic treatment and long term
- CHILD study
- CHILD subjects: 16S rRNA analysis
- Gut microbiota at 3-months vs. 1-year
- "Phenotype” effect on gut microbiota
- No obvious differences in diversity
- Order abundance at 3 months
- Family abundance at 3 months
- Genus abundance at 3 months
- qPCR confirmed differences
- No differences in family abundance at 1 year
- Major differences in predicted differences
- Differences in SCFA in feces at 3 months
- Microbially influenced host metabolites in urine
- Determining effect of 4 species in mice
- Human microbiota transfer
- FLVR colonizes mice with human feces
- FLVR reduces lung inflammation
- FLVR attenuates inflammatory cytokines in lung
- FLVR attenuates IgG2a specific to Ova
- Summary
- Acknowledgements
Topics Covered
- Hygiene hypothesis
- "Disappearing microbe" hypothesis
- Antibiotic use and asthma susceptibility
- Animal model study
- Cohort study in children
- Microbiota transfer study
- Update interview: Role of early life microbiome in immune system development
- Update interview: Microbes, immune development and asthma susceptibility
- Update interview: Life events can determine likelihood of developing asthma
- Update interview: Effect of breastfeeding, antibiotics, C-section and pets on microbiome composition
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Finlay, B.B. (2021, March 3). Role of the microbiota in asthma [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/AJMC8245.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. B. Brett Finlay has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Update Available
The speaker addresses developments since the publication of the original talk. We recommend listening to the associated update as well as the lecture.
- Full lecture Duration: 29:54 min
- Update Interview Duration: 9:11 min
A selection of talks on Microbiology
Transcript
Please wait while the transcript is being prepared...
0:00
Hi, I'm Brett Finlay.
The talk today is about the Role
of the Microbiota in Asthma.
And I'm situated
in the University
of British Columbia,
in Vancouver, BC.
0:11
So there's a lot of discussion
about why diseases,
characteristic of
Western nations, are increasing.
And one of the concepts
that's being kicked around
is something called
the hygiene hypothesis,
and this suggests that,
perhaps, we're actually living
too cleanly in our childhood now
and we're not
exposed to many microbes
we normally would have been
exposed to early in life.
And there's lack of exposure
early in life
might mean that later in life,
we actually
react to these things
in various
autoimmune type responses.
So we know
that infectious disease rates
have absolutely plummeted
in developed countries
over the last 50 years.
This is due
to the advent of vaccines,
antibiotics, and also our quest
to clean up our world.
We sterilize water,
we ensure food is safe,
and we really have done
everything in our control
to get rid of microbes,
and as a result,
we have succeeded
in really decreasing
infectious disease rates.
However, in those same 50 years,
we've seen a massive spike
in what we call
Western lifestyle diseases.
These are obesity,
type-1 diabetes,
asthma, et cetera.
And this has corresponded
precisely with the decreased
infectious diseases.
And this has
led to the current concept that,
well, maybe in our quest
to get rid of these infections,
we've actually cleaned up
our world too much,
and as a result,
we're actually...
Microbes
might have something to do
with playing a role in how these
diseases may actually develop.
1:33
So Martin Blaser has championed
a term he calls
the "disappearing microbe"
hypothesis,
that is, that we are killing off
all our microbes
that are normally beneficial,
and each generation,
we have less and less microbes.
So, you know, the average
child gets
10-12 courses of antibiotics
before they get to school,
and we also know that
antibiotics
have a drastic effect
on the microbes in and on us.
So on the graph shown on this
is just really
a characterization
of the microbiota
in three different mice,
an untreated mouse,
a streptomycin-treated mouse,
and a metronidazole-treated
mouse.
Streptomycin and Metronidazole
are two antibiotics
that obviously
kill different microbes.
But the take home message
here is that
by using these antibiotics,
we're affecting
many, many microbes
and entire microbial composition
that is the microbiota
found in these animals.
So the idea is that
as we clean our world up,
we use all these antibiotics
and we try and get rid off
all these microbes
that maybe we actually
can't even go back
to have the microbes that
our great, great grandfathers
and grandparents actually had.
So maybe, this is causing
these microbes to disappear,
and maybe
this is also compounding
these Western lifestyle
type diseases.